Introduction {#s1}
============

Genome-wide association studies (GWAS) have discovered thousands of genetic loci associated with complex traits and diseases. However, identifying candidate causal genes and molecular mechanisms at these loci remains challenging. Complex trait-associated variants are enriched in regulatory elements and are therefore thought to act via regulation of gene expression levels, often in a cell type- and context-specific manner ([@bib3]; [@bib23]; [@bib40]). However, such variants are equally enriched among splicing quantitative trait loci (QTLs) ([@bib26]; [@bib47]) and incorporating splicing QTLs in a transcriptome-wide association study increased the number of disease-associated genes by twofold ([@bib48]). In addition to splicing, genetic variants can also alter transcript sequence by regulating promoter and 3ʹ end usage, which we refer to collectively hereafter as transcript usage QTLs (tuQTLs). Alternative transcript start and end sites underlie most transcript differences between tissues ([@bib61]; [@bib66]), they are dynamically regulated in response to cellular stimuli ([@bib1]; [@bib67]) and they are also frequently dysregulated in cancer ([@bib18]; [@bib46]). Moreover, experimental procedures designed to capture either 5ʹ or 3ʹ ends of transcripts have identified disease-relevant genetic variants that regulate promoter or 3ʹ end usage ([@bib28]; [@bib84]). However, well-powered RNA-seq-based tuQTL studies performed across cell types ([@bib9]; [@bib15]; [@bib44]; [@bib47]; [@bib60]) and conditions ([@bib54]; [@bib80]) have thus far not distinguished between promoter usage, splicing and 3ʹ end usage. Thus, how these distinct transcriptional mechanisms contribute to complex traits and how context-specific these genetic effects are is currently unclear.

In addition to splicing analysis, RNA-seq data can also be used to quantify promoter and 3ʹ end usage. The simplest approach would be to first quantify the expression of all annotated transcripts using one of the many quantification algorithms (benchmarked in [@bib73]). Linear regression can then be used to identify genetic variants that are associated with the usage of each transcript of a gene ([@bib48]; [@bib60]). Comparing the associated transcripts to each other can reveal which transcriptional changes take place ([Figure 1A](#fig1){ref-type="fig"}). A key assumption here is that all expressed transcripts are also part of the annotation catalog. If some of the expressed transcripts are missing, then reads originating from the missing transcripts might be erroneously assigned to other transcripts that are not expressed at all ([Figure 1B](#fig1){ref-type="fig"}) ([@bib71]). This can lead to individual genetic variants being spuriously associated with multiple transcriptional changes. For example, a genetic variant regulating promoter usage might also appear to be associated with the inclusion of an internal exon ([Figure 1B](#fig1){ref-type="fig"}), although there are no reads originating from that exon. Importantly, this is not just a theoretical concern, because 25--35% of the exon-exon junctions observed in RNA-seq data are not present in transcript databases ([@bib60]), and up to 60% of the transcripts annotated by Ensembl ([@bib81]) are truncated at the 5ʹ or 3ʹ end ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

![Challenges of quantifying transcript usage from RNA-seq data.\
Transcript quantification seeks to estimate the most likely configuration of *known* transcripts that best explains observed read counts supporting the inclusion of each exon. (**A**) In scenario A, each copy of the G allele increases the usage of transcript 2 by 10%. Since both expressed transcripts (transcript 1 and transcript 2) are annotated, we successfully detect the change and conclude that the G allele increases the expression of the proximal promoter of the gene. (**B**) In scenario B, each copy of the G allele still increases the usage of transcript 2 by 10%. However, since transcript 2 is missing from the annotations, reads originating from transcript 2 are now falsely assigned to transcript 3. Since transcript 3 also contains alternative second exon, we now falsely conclude that in addition to promoter usage, the G allele is also associated with increased inclusion of exon 2, even though there are no reads mapping to exon 2. Furthermore, the magnitude of the genetic effect is underestimated, because the reads assigned to transcript 3 are assumed to be evenly distributed across the promoter and the alternative exon. (**C**) Top panel: Two hypothetical transcripts that differ from each other at the promoter, at an internal exon and at the 3ʹ end. Middle panel: Leafcutter uses reads mapping to exon-exon junctions to identify alternatively excised introns. Bottom panel: txrevise uses the exons shared between transcripts (dark blue) as a scaffold to construct three independent transcriptional events from the two original transcripts.](elife-41673-fig1){#fig1}

To overcome the issue of missing transcript annotations, recent tuQTL studies have focussed on quantifying transcription at the level of individual exons ([@bib22]; [@bib44]; [@bib57]), introns ([@bib57]) or exon-exon junctions ([Figure 1C](#fig1){ref-type="fig"}) ([@bib48]; [@bib57]; [@bib60]). While these approaches often discover complementary genetic associations ([@bib57]; [@bib60]), they do not explicitly reveal the transcriptional mechanism (promoter usage, alternative splicing or 3ʹ end usage) underlying the genetic associations. The most successful approach to differentiate between distinct transcriptional mechanisms has been 'event-level' analysis where reference transcripts are split into independent events (e.g. promoters, splicing events and 3ʹ ends) whose expressions is then quantified using standard transcript quantification methods ([Figure 1C](#fig1){ref-type="fig"}). This approach was pioneered by MISO ([@bib37]) and was recently used to identify promoter usage QTLs in the GEUVADIS dataset ([@bib67]). Despite its success, MISO covers only a subset of promoter events (alternative first exons) and its event annotations have not been updated since it was first published. Thus, there is a need for a method that is able to detect a comprehensive set of promoter, splicing and 3ʹ end usage QTLs in an uniform manner.

In this study, we re-analysed RNA-seq data from human induced pluripotent stem cell-derived macrophages (IPSDMs) exposed to three inflammatory stimuli (18 hr IFNɣ stimulation, 5 hr *Salmonella* infection and IFNɣ stimulation followed by *Salmonella* infection) ([@bib3]). We also collected a new dataset of IPSDMs from 70 individuals stimulated with acetylated LDL (acLDL) for 24 hr. We mapped genetic associations at the level of total gene expression, full-length transcript usage and exon-exon junction usage in each experimental condition. In addition to existing quantification methods, we also developed a complementary approach (txrevise) that stratifies reference transcript annotations into independent promoter, splicing and 3ʹ end events. Using txrevise, we found that promoter and 3ʹ end usage QTLs constituted 55% of detected tuQTLs, exhibited distinct genetic architectures from canonical expression or splicing QTLs, and often colocalised with complex trait associations. Promoter usage QTLs were also 50% more likely to be context-specific than canonical splicing QTLs. Thus, context-specific regulation of promoter usage might be a previously underappreciated molecular mechanism underlying complex trait associations.

Results {#s2}
=======

Quantifying transcript usage in stimulated macrophages {#s2-1}
------------------------------------------------------

We analysed RNA-seq data from human induced pluripotent stem cell (iPSC)-derived macrophages exposed to three inflammatory stimuli (18 hr IFNɣ stimulation, 5 hr *Salmonella* infection, and IFNɣ stimulation followed by *Salmonella* infection) and one metabolic stimulus (24 hr acLDL stimulation). While the gene expression analysis of the IFNɣ+*Salmonella* dataset from 84 individuals has previously been described ([@bib3]), the acLDL data from 70 individuals was newly generated for the current study. The acLDL dataset allowed us to assess how our results generalise to weaker, non-inflammatory stimuli. Both datasets included independent unstimulated control samples (denoted as 'naive' and 'Ctrl'). In each condition, we quantified gene expression and transcript usage using the following established quantification approaches: (i) gene-level read count quantified with featureCounts ([@bib49]), (ii) full-length transcript usage quantified with Salmon ([@bib62]) ([Figure 1C](#fig1){ref-type="fig"}), and (iii) exon-exon junction usage quantified with Leafcutter ([@bib48]) ([Figure 1C](#fig1){ref-type="fig"}).

Inspired by event level analysis proposed by MISO ([@bib37]; [@bib67]), we also developed a complementary approach (txrevise) to stratify reference transcript annotations into independent promoter, splicing and 3ʹ end events. To achieve this, txrevise identifies constitutive exons shared between all transcripts of a gene and uses those to assign non-constitutive exons to promoter, internal exon or 3ʹ end events ([Figure 1C](#fig1){ref-type="fig"}). Since up to 60% of the transcripts annotated by Ensembl ([@bib81]) are truncated at the 5ʹ or 3ʹ end ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), txrevise extends truncated transcripts by copying over exons from the longest transcript of the gene ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). This step eliminates a large number of implausible alternative promoter and 3ʹ end events that lack experimental evidence. To make the approach suitable for genes with non-overlapping transcripts, we also select a subset of transcripts that share the largest number of exons between them ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Finally, to ensure that the new alternative promoter and 3ʹ end events do not capture splicing changes, txrevise masks alternative exons in promoter and 3ʹ end events that are not the first or last exons ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Although this means that some splicing events near the promoters and 3ʹ ends of the genes may remain undetected by txrevise, it is a trade-off that improves the overall interpretability of txrevise tuQTLs. The R package as well as custom transcriptional events constructed by txrevise are available from GitHub (<https://github.com/kauralasoo/txrevise>; [@bib4]).

Genetic effects on transcript usage {#s2-2}
-----------------------------------

Depending on the experimental condition and quantification method, we detected between 1500 and 3500 QTLs at a 10% false discovery rate (FDR) ([Figure 2A](#fig2){ref-type="fig"}). Leafcutter consistently detected the lowest number of QTLs per condition, while txrevise detected approximately 30% more associations than other methods ([Figure 2A](#fig2){ref-type="fig"}), 55% of which affected promoter or 3ʹ end usage instead of internal exons ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). However, this increase in QTLs can be partially explained by the fact that txrevise detected multiple associations for \~24% of the genes while the full-length tuQTL analysis was limited to single lead association per gene ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}, [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Some of these additional QTLs are likely to represent independent causal variants, such as the three independent tuQTLs detected for the *IRF5* gene ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}) while others could be explained by technical biases such as large gene expression QTL (eQTL) effects ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}) or positional biases in the RNA-seq data ([Figure 2---figure supplement 6](#fig2s6){ref-type="fig"}). Alternatively, additional associations could also be caused by transcriptional coupling where promoter or 3ʹ end choice directly influences the splicing of an internal exon or *vice versa* ([@bib6]; [@bib13]).

![Diversity of QTLs detected by different quantification methods.\
In panels A-C, all txrevise QTLs from promoters, internal exons and 3ʹ ends have been pooled to facilitate comparison with eQTLs as well as Leafcutter and full-length transcript usage QTLs. (**A**) Number of QTLs detected by read count, full-length transcript usage, Leafcutter and txrevise methods in each condition (N, naive; I, IFNɣ; S, *Salmonella*; I + S, IFNɣ+*Salmonella*; Ctrl; AcLDL) at 10% FDR. The number of QTLs detected by Leafcutter and txrevise are reported at the level of independent events (intron clusters or promoters/internal exons/3ʹ ends) and can include multiple QTLs per gene ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). The quantile-quantile plots are presented in [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}. (**B**) Sharing of QTLs detected by four quantification methods. The numbers on the heatmap show the fraction of QTLs detect by one method that were replicated by each of the three other methods (r^2^ \>0.8 between lead variants). Only QTLs with FDR \< 0.01 were included in the analysis. (**C**) Enrichment of genomic annotations at QTLs detected by the four quantification methods. (**D**) Comparison of Leafcutter tuQTLs to promoter, internal exon and 3ʹ end usage QTLs detected by txevise. Genomic annotations used for enrichment analysis: *promoter* - promoter flanking regions (−2000 bp to +200 bp); *5ʹ UTR, coding, intron, 3ʹ UTR* - corresponding regions extracted from Ensembl transcripts; *poly(A)* - experimentally determined polyadenylation sites (±25 bp) ([@bib30]); *open chromatin* - open chromatin regions from macrophages ([@bib3]); *splicing factor* - experimentally determined binding sites of splicing factors detected by eCLIP ([@bib76]). The points on panels C and D show the natural logarithm of enrichment for each annotation and the lines represent the 95% confidence intervals from fgwas ([@bib64]).](elife-41673-fig2){#fig2}

Different quantification methods may be biased towards discovering events with specific genomic properties, which is not captured by the number of QTLs detected. To address this, we quantified how often the lead QTL variants (FDR \< 0.01) from different methods were in high linkage disequilibrium (LD) (r^2^ \>0.8) with each other (see Materials and methods). Consistent with previous reports that tuQTLs are largely independent from eQTLs ([@bib47]), we found that only 11--25% of the lead variants detected at the read count level replicated at the transcript level (r^2^ \>0.8, irrespective of the replication p-value), independent of which quantification method was used ([Figure 2B](#fig2){ref-type="fig"}). In contrast, \~50% of the Leafcutter QTLs were also detected by txrevise or full-length transcript usage approaches. Similarly, the tuQTLs detected by txrevise and full-length transcript usage quantification were in high LD more than 60% of the time ([Figure 2B](#fig2){ref-type="fig"}). Finally, we found that while 44% of the txrevise internal exon QTLs were in high LD with Leafcutter QTLs, this decreased to \~20% for promoter and 3ʹ end QTLs ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that Leafcutter is less suited to capture those events. Thus, different quantification approaches appear to capture complementary sets of genetic associations.

Genomic properties of transcript usage QTLs {#s2-3}
-------------------------------------------

To characterise the genetic associations detected by different quantification methods, we compared the relative enrichments of the identified QTLs across multiple genomic annotations. We constructed genomic tracks for eight annotations: open chromatin measured by ATAC-seq ([@bib3]), promoter flanking regions (−2000 bp to +200 bp), 5ʹ UTRs, coding sequence (CDS), introns, 3ʹ UTRs, polyadenylation sites ([@bib30]), and eCLIP-binding sites for RNA-binding proteins involved in splicing regulation (splicing factors) ([@bib76]). We then used the hierarchical model implemented in fgwas ([@bib64]) to estimate the enrichment of each genomic annotation among the QTLs detected by each quantification method. Consistent with the limited overlap between eQTLs and tuQTLs ([Figure 2B](#fig2){ref-type="fig"}), we found that eQTLs were strongly enriched in sites of open chromatin ([Figure 2C](#fig2){ref-type="fig"}; log enrichment of 3.31, 95% CI \[3.15, 3.47\]), whereas all transcript-level QTLs were enriched at the binding sites of splicing factors detected by eCLIP ([Figure 2C](#fig2){ref-type="fig"}, mean log enrichment of 2.29). Importantly, when all txrevise tuQTLs were pooled, the enrichment patterns were broadly similar to tuQTLs detected by full-length Ensembl transcripts ([Figure 2C](#fig2){ref-type="fig"}). This suggests that txrevise events and full-length transcripts capture similar genetic associations but txrevise facilitates more accurate identification of the underlying transcriptional event (i.e. promoter, internal exon or 3ʹ end usage) ([Figure 2B](#fig2){ref-type="fig"}). Finally, compared to Leafcutter, full-length transcript usage and txrevise QTLs were both more strongly enriched at 3ʹ UTRs ([Figure 2C](#fig2){ref-type="fig"}, mean log enrichment of 1.85), suggesting that they capture changes in 3ʹ UTR length that do not manifest at the level of junction reads and are thus missed by Leafcutter.

To compare different types of transcriptional events, we repeated the fgwas analysis on the promoter, internal exon and 3ʹ end QTLs detected by txrevise as well as Leafcutter splicing QTLs. We found that Leafcutter and internal exon QTLs showed broadly similar enrichment patterns, with a strong enrichment at the binding sites of splicing factors ([Figure 2D](#fig2){ref-type="fig"}, mean log enrichment of 2.53). In contrast, promoter and 3ʹ end usage QTLs were specifically enriched at promoters ([Figure 2D](#fig2){ref-type="fig"}; log enrichment of 2.76, 95% CI \[2.59, 2.95\]) and 3ʹ UTRs ([Figure 2D](#fig2){ref-type="fig"}; log enrichment of 3.60, 95% CI \[3.43, 3.76\]), respectively ([Figure 2D](#fig2){ref-type="fig"}), and showed only a modest enrichment at the binding sites of splicing factors ([Figure 2D](#fig2){ref-type="fig"}; mean log enrichment of 1.17). Compared to other events, promoter usage QTLs were relatively more enriched in open chromatin regions (log enrichment of 1.58, 95% CI \[1.42, 1.74\]). Thus, promoter usage, splicing and 3ʹ end usage appear to be regulated by largely independent sets of genetic variants enriched in distinct genomic regions.

Motivated by the enrichment of promoter usage QTLs in open chromatin regions ([Figure 2D](#fig2){ref-type="fig"}), we analysed chromatin accessibility QTLs that we previously identified in a subset of 41 individuals of the same study ([@bib3]). We wanted to determine how often changes in promoter usage also manifest at the level of promoter accessibility. We found that 124/786 (15.8%) of the promoter usage QTLs were in high LD with at least one chromatin accessibility QTL (r^2^ \>0.9) compared to 10.2% of the internal exon and 3ʹ end usage QTLs (Fisher's exact test p-value=3.87×10^−5^). These overlaps could correspond to both distal regulatory elements affecting promoter usage or direct changes in local promoter accessibility. To focus on local promoter accessibility, we further required the center of the accessible region to be no farther than 1000 bp from the closest promoter of the gene, leaving 46/786 (5.8%) promoter usage QTLs with a putative coordinated effect on promoter accessibility. One such example affecting promoter usage and promoter accessibility of the *HDLBP* gene is highlighted in [Figure 2---figure supplement 7](#fig2s7){ref-type="fig"}. However, larger studies with increased statistical power are needed to characterise the true extent of coordination between promoter accessibility and promoter usage.

Colocalisation with complex trait associations {#s2-4}
----------------------------------------------

To assess the relevance of different QTLs for interpreting complex trait associations, we performed statistical colocalisation analysis with GWAS summary statistics for 33 immune-mediated and metabolic traits and diseases (see Materials and methods). We found that 47 of 138 colocalised QTLs influenced total gene expression level ([Figure 3A](#fig3){ref-type="fig"}) (PP3+PP4 \>0.8, PP4/PP3 \>9; PP3, posterior probability of a model with two distinct causal variants; PP4, posterior probability of a model with one common causal variant). In contrast, the remaining 91 colocalised QTLs were associated with at least one of the transcript-level phenotypes (full-length transcript usage, txrevise or Leafcutter) but not with total gene expression ([Figure 3A](#fig3){ref-type="fig"}). Similarly, 44 of 91 transcript-level colocalisations were detected only by a single transcript quantification approach ([Figure 3A](#fig3){ref-type="fig"}). An important caveat of this analysis is that it does not directly test if the colocalisations are specific to one quantification method or simply missed by others because of limited power. Thus, our estimates of method-specificity are likely to be inflated.

![Overlap of colocalised gene-trait pairs detected by the four quantification methods across 33 complex traits.\
The UpSetR plot is an alternative to Venn diagrams for visualising intersection of multiple sets ([@bib16]). The horizontal bars show the total number of colocalised trait-gene pairs detected by each quantification method. The dark circles indicate different patterns of sharing between the quantification methods and the vertical bars show how many gene-trait pairs followed a given sharing pattern. For example, in panel A, the first column shows that 34 colocalised gene-trait pairs were detected only at the total read count level but not at the transcript level. Similarly, the second column shows that 21 colocalised gene-trait pairs were detected by all transcript-level methods but not by total read count. (**A**) Sharing of colocalised gene-trait pairs between the four quantification methods. (**B**) Sharing of colocalised gene-trait pairs between Leafcutter and three independent txrevise event types (promoters, internal exons, 3ʹ ends).](elife-41673-fig3){#fig3}

Finally, to quantify the relative contribution of promoter usage, splicing and 3ʹ end usage to complex traits, we stratified the txrevise colocalisations by transcriptional event type. We found that 44 of 77 colocalised QTLs influenced internal exons and the rest regulated promoters and 3ʹ ends ([Figure 3B](#fig3){ref-type="fig"}). We were able to replicate known associations between splicing of exon two in *CD33* and Alzheimer's disease ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) ([@bib52]) and splicing of exon 13 in *HMGCR* and LDL cholesterol ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) ([@bib14]). Importantly, while half of the promoter and internal exon colocalisations were also detected by Leafcutter, only 1/10 3ʹ end events were captured by Leafcutter, probably because these are less likely to manifest at the level of junction reads ([Figure 3B](#fig3){ref-type="fig"}).

Condition-specificity of expression and transcript usage QTLs {#s2-5}
-------------------------------------------------------------

Next, we explored how the genetic effects of eQTLs and tuQTLs varied in response to stimuli. To define response QTLs, we started with QTLs detected (FDR \< 10%) in each of the four simulated conditions (I, S, I + S and acLDL) and used an interaction test to identify cases where the QTL effect size was significantly different between the simulated and corresponding naive condition (FDR \< 10%). To exclude small but significant differences in effect size, we used a linear mixed model to identify QTLs where the interaction term explained more than 50% of the total genetic variance in the data (see Materials and methods). Although the fraction of QTLs that were response QTLs varied greatly between conditions ([Figure 4A](#fig4){ref-type="fig"}) and correlated with the number of differentially expressed genes ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) as previously reported ([@bib40]), we found that the fraction of response tuQTLs was relatively consistent between the four quantification methods ([Figure 4A](#fig4){ref-type="fig"}). While previous reports have highlighted that eQTLs are more condition-specific than tuQTLs ([@bib54]), we found no clear pattern in our data with stronger stimuli (S and I + S) showing larger fraction of condition-specific eQTLs, and weaker stimuli (I, acLDL) showing smaller fraction of response eQTLs ([Figure 4A](#fig4){ref-type="fig"}) compared to tuQTLs. However, when we focussed on the transcriptional events detected by txrevise, we found that promoter usage QTLs were 50% more likely to be response QTLs than tuQTLs regulating either internal exons or 3ʹ ends ([Figure 4B](#fig4){ref-type="fig"}) (Fisher's exact test combined p-value=2.79×10^−6^).

![Condition-specificity of eQTLs and tuQTLs.\
(**A**) Fraction of all QTLs detected in each simulated condition that are response QTLs (FDR \< 10% and more than 50% of the genetic variance explained by the interaction term). (**B**) Fraction of txrevise tuQTLs classified as response QTLs, stratified by the part of the gene that they influence (promoters, internal exons or 3ʹ ends). (**C**) Fraction of GWAS colocalisations that are response QTLs. (**D**) Colocalisation between a GWAS hit for rheumatoid arthritis (RA) and IFNɣ-specific tuQTL at the *CD40* locus. PP4 represents the posterior probability from coloc ([@bib29]) that the GWAS and QTL signals share a single causal variant. The dots are shaded according to r^2^ from the lead RA GWAS variant. (**E**) Top panel: The lead GWAS variant (rs4239702) is associated with increased expression of the short 5ʹ UTR of the *CD40* gene. Bottom panel: Ensembl annotations couple the short 5ʹ UTR to skipped exon 6, but this is not supported by RNA-seq data ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). FPM, fragments per million. (**F**) Relative expression of the short 5ʹ UTR stratified by the genotype of the lead GWAS variant. N, naive; I, IFNɣ; S, *Salmonella*; I + S, IFNɣ+*Salmonella*.](elife-41673-fig4){#fig4}

Finally, we assessed the condition-specificity of QTLs that colocalised with complex trait loci. We found that, on average, 12% of the GWAS colocalisations corresponded to response QTLs ([Figure 4C](#fig4){ref-type="fig"}). One example is an IFNɣ-specific promoter usage QTL for the *CD40* gene that colocalises with a GWAS signal for rheumatoid arthritis ([@bib58]). The alternative C allele of the rs4239702 variant is associated with increased usage of the transcript with the short 5ʹ UTR ([Figure 4E,F](#fig4){ref-type="fig"}). This tuQTL was also visible at the absolute expression level of the two alternative promoters ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), but was missed by Leafcutter, because there is no change in junction reads. Although the variant was not significantly associated with total gene expression level ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), the two promoters contain the same start codon. As a result, the likely functional consequence of the *CD40* tuQTL is modulation of protein abundance. Although the same tuQTL was also detected at the full-length transcript usage level, the affected transcripts also differ from each other by alternatively spliced exon 6, making it challenging to interpret the result ([Figure 4E](#fig4){ref-type="fig"}). The preferential upregulation of the transcript with the short 5ʹ UTR after exposure to an inflammatory stimulus is also supported by FANTOM5 capped analysis of gene expression (CAGE) data from primary macrophages ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}) ([@bib7]).

Discussion {#s3}
==========

We have performed a comprehensive analysis of the genetic determinants of transcript usage in human iPSC-derived macrophages exposed to four different stimuli. Our approach to stratify transcripts into individual events greatly improved the interpretability of molecular mechanisms underlying tuQTLs. Consequently, we were able to discover that 55% of the transcript-level associations affected promoter or 3ʹ end usage and these variants were enriched in markedly different genomic features relative to canonical splicing QTLs. We also found that promoter usage QTLs were 50% more likely to be condition-specific than other transcriptional events and often colocalised with GWAS hits for complex traits. Thus, event-level analysis might be preferable over transcript-level analysis when the aim is to identify specific transcriptional changes underlying genetic associations.

We were able to link 6% of the promoter usage QTLs to coordinated changes in promoter accessibility. A likely reason for such a small overlap is limited statistical power in our chromatin accessibility dataset that contained only 41 individuals, leading us to miss many true effects on promoter accessibility. Alternatively, as other studies have suggested, promoter accessibility might not be an accurate proxy of activity and may merely be a prerequisite for transcription to take place ([@bib65]), but demonstrating this would require better powered datasets to confidently demonstrate lack of effect on promoter accessibility. There is a great potential to study this further in larger datasets that have profiled gene expression, chromatin accessibility or histone modifications in hundreds of individuals ([@bib15]; [@bib42]).

Choosing the optimal quantification method for RNA-seq data is a challenging problem. The field of detecting and quantifying individual transcriptional changes from RNA-seq data has been developing rapidly. One of the most successful approaches has been the use of reads spanning exon-exon junctions to detect differential usage of individual exons within genes. In our study, we used Leafcutter to perform junction-level analysis, but other options are available such as JUM ([@bib79]) or MAJIQ ([@bib77]). A key advantage of junction-level analysis is that it can discover novel exon-exon junctions and is thus well-suited for characterising rare or unannotated splicing events. On the other hand, changes in 5ʹ and 3ʹ UTR length are not captured by junction-level methods, because these events do not overlap exon-exon junctions. Changes in UTR length can only be detected by methods that consider all reads originating from alternative transcript ends such as MISO ([@bib37]) or txrevise proposed here. MISO provides more fine-grained events that can differentiate between various types of splicing events. Txrevise, on the other hand, provides a more comprehensive catalog of promoter and 3ʹ end events that can be continuously updated as reference annotations improve. A promising alternative to both of these methods is Whippet, which quantifies transcriptional events by aligning reads directly to the splice graph of the gene ([@bib72]). Thus, no single approach is consistently superior to others and characterizing the full spectrum of transcriptional consequences of genetic variation requires a combination of analytical strategies ([@bib57]; [@bib60]).

An important limitation of txrevise is that it is only able to quantify splicing events present in reference transcript databases. However, our approach can easily be extended by incorporating additional annotations such experimentally determined promoters from the FANTOM5 ([@bib25]) projects or alternative polyadenylation sites from the PolyAsite database ([@bib30]), as is done by QAPA ([@bib32]). Another option might be to incorporate novel transcripts identified by transcript assembly methods such as StringTie ([@bib63]) into existing annotation databases. Nevertheless, since txrevise relies on Salmon for event-level quantification, it is still susceptible to some of the same limitations as full-length transcript quantification. Even though event-level analysis reduces the problem slightly, a positive transcript expression estimate does not guarantee that any specific exon is actually present in the transcript, especially if the transcript annotations are incomplete ([Figure 1B](#fig1){ref-type="fig"}) ([@bib71]). Secondly, large eQTL effects and positional biases in the RNA-seq data can occasionally lead to spurious changes in transcript usage ([Figure 2---figure supplements 5](#fig2s5){ref-type="fig"} and [6](#fig2s6){ref-type="fig"}). Therefore, it is important to visually confirm candidate transcriptional events using either base-level read coverage plots ([@bib2]) or Sashimi plots ([@bib38]) before embarking on follow-up experiments.

A key aim of QTL mapping studies is to elucidate the molecular mechanisms underlying complex trait associations. In our analysis, we found that over 50% of the genetic effects that colocalise with complex traits regulated transcript usage and did not manifest at the total gene expression level. Moreover, 42% of the transcript-level colocalisations affected promoter or 3ʹ end usage instead of splicing of internal exons. Importantly, no single quantification method was able to capture the full range of genetic effects, confirming that different quantification approaches often identify complementary sets of QTLs ([@bib57]; [@bib60]). Thus, there is great potential to discover additional disease associations by re-analysing large published RNA-seq datasets such as GTEx ([@bib10]) with state-of-the-art quantification methods.

Materials and methods {#s4}
=====================

Cell culture and reagents {#s4-1}
-------------------------

### Donors and cell lines {#s4-1-1}

Human induced pluripotent stem cells (iPSCs) lines from 123 healthy donors (72 female and 51 male) ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) were obtained from the HipSci project ([@bib39]). Of these lines, 57 were initially grown in feeder-dependent medium and 66 were grown in feeder-free E8 medium. The cell lines were screened for mycoplasma by the HipSci project ([@bib39]). All samples for the HipSci project ([@bib39]) were collected from consented research volunteers recruited from the NIHR Cambridge BioResource (<http://www.cambridgebioresource.org.uk>). Samples were initially collected under ethics for iPSC derivation (REC Ref: 09/H0304/77, V2 04/01/2013), which require managed data access for all genetically identifying data. Later samples were collected under a revised consent (REC Ref: 09/H0304/77, V3 15/03/2013) under which all data, except from the Y chromosome from males, can be made openly available. The ethics approval was obtained from East of England - Cambridge East Research Ethics Committee. The iPSC lines used in this study are commercially available via the European Collection of Authenticated Cell Cultures. No new primary human samples were collected for this study.

The details of the iPSC culture, macrophage differentiation and stimulation for the IFNɣ+*Salmonella* study have been described previously ([@bib3]) ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Macrophages for the acLDL study were obtained from the same differentiation experiments.

### AcLDL stimulation {#s4-1-2}

Macrophages differentiated from a total of 71 iPSC lines were used for the acLDL stimulation. The final sample size was decided on the basis of similar gene expression and splicing QTL mapping studies performed previously ([@bib3]; [@bib47]; [@bib54]). Macrophages were grown in RPMI 1640 (Gibco) supplemented with 10% FBS (labtech), 2 mM L-glutamine (Sigma) and 100 ng/ml hM-CSF (R and D) at a cell density of 150,000 cells per well on a six-well plate. On day 6 of the macrophage differentiation, two wells of the six-well plate were exposed to 100 µg/ml human acLDL (Life Technologies) for 24 hr, whereas the other two wells were incubated in fresh RPMI 1640 medium without stimulation throughout this period.

For RNA extraction, cells were washed once with PBS and lysed in 300 µl of RLT buffer (Qiagen) per well of a six-well plate. Lysates from two wells were immediately pooled and stored at −80°C. RNA was extracted using a RNA Mini Kit (Qiagen) following the manufacturer's instructions and eluted in 35 µl nuclease-free water. RNA concentration was measured using NanoDrop, and RNA integrity was measured on Agilent 2100 Bioanalyzer using a RNA 6000 Nano Total RNA Kit.

RNA sequencing and quality control {#s4-2}
----------------------------------

All RNA-seq libraries from the acLDL study were constructed manually using poly-A selection and the Illumina TruSeq stranded library preparation kit. The TruSeq libraries were quantified using Bioanalyzer and manually pooled for sequencing. The samples were sequenced on Illumina HiSeq 2000 using V4 chemistry and multiplexed at six samples/lane. The control and acLDL stimulated RNA samples from a single donor were always sequenced in the same experimental batch. Sample metadata is presented in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. RNA-seq reads from both studies were aligned to the GRCh38 reference genome and Ensembl 87 transcript annotations using STAR v2.4.0j ([@bib19]). Subsequently, VerifyBamID v1.1.2 ([@bib36]) was used to detect and correct any sample swaps between donors. Two samples from one donor (HPSI0513i-xegx_2) were excluded from downstream analysis, because they appeared to be outliers on the principal component analysis (PCA) plot of the samples.

Quantifying gene and transcript expression {#s4-3}
------------------------------------------

We used four alternative strategies to quantify transcription from RNA-seq data: (i) gene-level read count quantified with featureCounts ([@bib49]), (ii) full-length transcript usage quantified with Salmon ([@bib62]) ([Figure 1C](#fig1){ref-type="fig"}), (iii) promoter, internal exon and 3ʹ end usage quantified with txrevise, and (iv) exon-exon junction usage quantified with Leafcutter ([@bib48]).

### Gene-level read counts {#s4-3-1}

We used featureCounts v1.5.0 ([@bib49]) to count the number of uniquely mapping fragments overlapping transcript annotations from Ensembl 87. We excluded short RNAs and pseudogenes from the analysis leaving 35,033 unique genes of which 19,796 were protein coding. Furthermore, in both IFNɣ+*Salmonella* and acLDL dataset, we used only genes with mean expression in at least one of the conditions greater than one transcripts per million (TPM) ([@bib78]) in all downstream analyses. This resulted in 12,660 and 12,103 genes included for analysis in the IFNɣ+*Salmonella* and acLDL datasets, respectively. We quantile-normalised the data and corrected for sample-specific GC content bias using the conditional quantile normalisation (cqn) ([@bib33]) R package as recommended previously ([@bib21]).

### Full-length transcript usage {#s4-3-2}

We downloaded the FASTA files with messenger RNA (mRNA) and non-coding RNA sequences from the Ensembl website (version 87). We concatenated the two files and used salmon v0.8.2 ([@bib62]) with '\--seqBias \--gcBias \--libType ISR' options to quantify the expression level of each transcript. We used tximport ([@bib70]) package to import the expression estimates into R and calculated the relative expression of each transcript by dividing the TPM expression estimate of each transcript with the sum of the expression estimates of all transcripts of the gene.

### Quantifying transcriptional events with txrevise {#s4-3-3}

We downloaded exon coordinates for all Ensembl 87 transcripts using the makeTxDbFromBiomart function from the GenomicFeatures ([@bib45]) R package. We also downloaded metadata for these transcripts using the biomart ([@bib20]) R package. Finally, we extracted transcript tags from the GTF file downloaded from the Ensembl website using the extractTranscriptTags.py script available from the txrevise repository (<https://github.com/kauralasoo/txrevise>). This step was necessary, because Ensembl contains a large number of truncated transcripts (marked with cds_start_NF or cds_end_NF tags) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), but this information is not present in biomart.

We developed the txrevise R package to pre-process transcript annotations prior to quantification. First, we extended all truncated protein coding transcripts using exons from the longest annotated transcript of the gene that was part of the GENCODE Basic gene set ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We also performed the same step on transcripts annotated in Ensembl as retained_intron, processed_transcript or nonsense_mediated_decay, because they often ended abruptly in the middle of the exons and were unlikely to correspond to true transcription start and end sites.

Next, we focused on splitting full-length transcripts into alternative promoters, internal exons and 3ʹ ends. However, some genes contained either non-overlapping transcripts or very short transcripts that complicated this process. Thus, for each gene we first identified a group of transcripts that shared the largest number of exons with each other. We then used the shared exons as a scaffold to construct three types of independent transcriptional events: alternative promoters, internal exons and 3ʹ ends (group 1) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). We also repeated this process on a second group of transcripts that shared the second-most exons with each other (group 2) (see [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} for illustration). Thus, the original transcripts from each gene were split into up to six sets of transcriptional events (two sets of alternative promoters, internal exons and 3ʹ ends). Next, to ensure that the new alternative promoter and 3ʹ end events did not capture splicing changes, we masked all alternative exons that were not the first or last exons ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). We applied this step only to alternative promoter and 3ʹ end events and not to internal exon events. This final step can optionally be skipped to discover more association at the expense of losing some interpretability, because a subset of the promoter and 3ʹ end events might be tagging splicing changes. We used Salmon ([@bib62]) with '\--seqBias \--gcBias \--libType ISR' options to independently quantify the expression of each set of transcriptional events. Finally, we used tximport ([@bib70]) to import the event expression estimates into R and calculated the relative expression of each transcriptional event by dividing the TPM expression estimate of each event with the sum of the expression estimates of all events within the same group of transcripts. This normalisation was performed separately for each type of transcriptional event (promoters, internal exons and 3ʹ ends) and also separately for the two groups of transcripts used for constructing the alternative events, ensuring that the normalized value always represented the relative usage of one transcriptional event compared to other events of the same type that shared the same scaffold.

### Quantifying intron excision ratios with Leafcutter {#s4-3-4}

Finally, we used Leafcutter ([@bib48]) to quantify the relative excision frequencies of alternative introns. We used the spliced alignments from STAR as input to Leafcutter. We did not correct for reference mapping bias, because we wanted to be able to directly compare Leafcutter results with those from Salmon and there is no obvious way to correct for reference mapping bias in Salmon quantification. We used the default parameters of requiring at least 50 reads supporting each intron cluster and allowing introns of up to 500 kb in length.

Mapping expression and transcript usage QTLs {#s4-4}
--------------------------------------------

### Preparing genotype data {#s4-4-1}

We obtained imputed genotypes for all of the samples from the HipSci ([@bib39]) project. We used CrossMap v0.1.8 ([@bib82]) to convert variant coordinates from GRCh37 reference genome to GRCh38. Subsequently, we filtered the VCF file with bcftools v.1.2 to retain only bi-allelic variants (both SNPs and indels) with IMP2 score \>0.4 and minor allele frequency (MAF) \>0.05. We created a separate VCF files for the IFNɣ+*Salmonella* study (84 individuals) and the acLDL study (70 individuals). The same VCF files were used for all downstream analyses and were imported into R using the SNPRelate R package ([@bib83]).

### Association testing {#s4-4-2}

We used QTLTools ([@bib17]) to map QTLs in two stages. First, we used the permutation pass with '\--permute 10000 \--grp-best' options to calculate the minimal lead variant p-value for each feature (gene, transcript or splicing event) in a ± 100 kb window around each feature. We included the first six principal components of the phenotype matrix as covariates in the QTL analysis. The '\--grp-best' option ensured that in case of transcript usage QTLs, the permutation p-values were corrected for the number of alternative transcripts, exon-exon junction or transcriptional events tested. For txrevise, we performed the permutations across the two groups of transcripts what were used for event construction. Quantile-quantile plots confirmed that the permutation p-values were well calibrated ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Finally, we performed Benjamini-Hochberg FDR correction on the permutation p-values to identify QTLs that were significant at the 10% FDR level. For gene expression and full-length transcript usage QTLs this approach identified at most one lead variant per gene. For txrevise analysis we report up to three lead variants per gene: one for each independent transcriptional event type (promoters, internal exons, 3ʹ ends) ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). If the two groups of events identified different genetic associations, we report only the one lead variant that had the smallest permutation p-value across groups. Leafcutter analysis sometimes also identified multiple associations per gene if there were multiple independent intron clusters within those genes ([Figure 2---figure supplements 2](#fig2s2){ref-type="fig"} and [3](#fig2s3){ref-type="fig"}). Finally, we note that additional secondary associations could be discovered by performing conditional analysis on the QTLs that have already been detected, but we did not do that analysis.

Secondly, we used the nominal pass to calculate nominal association p-values in a ± 500 kb *cis* window around each feature. We used a larger *cis* window for the nominal pass to ensure that we did not have missing data in the colocalisation analysis (see below), where we used the ±200 kb *cis* window around each lead QTL variant. However, the colocalisation analysis was still based on the lead QTL variants identified in the ±100 kb window. Thus, even if a stronger QTL lead variant was detected in the ±500 kb window, this was not used for any downstream analysis.

QTL replication between quantification methods {#s4-5}
----------------------------------------------

To compare the QTLs detected by different quantification methods, we estimated the fraction of QTL lead variants detected by each method that were replicated by the other methods. Since read count and full-length transcript usage analysis were performed at the gene level, we decided to perform the replication analysis at the gene level as well. Because txrevise and Leafcutter quantified multiple events per gene and sometimes detected multiple independent QTLs ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), we picked the lead variant with the smallest p-value across all of the events quantified for a given gene as the gene-level lead variant. For each pairwise comparison of quantification methods, we first identified all lead variant-gene pairs with FDR \< 0.01 detected by the query method. Subsequently, we extracted the lead variants for the same genes detected by the replication method and estimated the fraction of those that were in high LD (r^2^ \>0.8) with each other. We then repeated this analysis for all pairs of quantification methods. Note that this measure is not necessarily symmetric between the quantification methods and also depends on the statistical power of each method. Since Leafcutter had lower statistical power than other methods on our dataset, it also replicated smaller fraction of QTLs detected by the other methods. In contrast, \~50% of the Leafcutter QTLs were replicated by txrevise and full-length transcript usage ([Figure 2B](#fig2){ref-type="fig"}).

We acknowledge that our definition of replication ignores the direction of the effect of the genetic variant on gene expression or transcript usage. For example, if Leafcutter detects a genetic variant that is associated with increased inclusion of an exon in a gene and txrevise detects that the same variant is associated with decreased inclusion of the same exon in the same gene, we would still consider it to be a 'successful' replication. However, in practice it is difficult to map Leafcutter events to specific Ensembl transcripts or txrevise events, especially if Leafcutter includes novel exon-exon junctions not present in the Ensembl database. Furthermore, comparing the effect size direction between eQTLs and tuQTLs is not possible, because any variant that is associated with increased usage of one transcript is by definition also associated with decreased usage of some other transcripts of the same gene.

QTL enrichment in genomics annotations {#s4-6}
--------------------------------------

### Constructing genomic annotations {#s4-6-1}

#### Gene features {#s4-6-1-1}

We downloaded transcript annotations from Ensembl version 87 ([@bib81]) using the GenomicFeatures ([@bib45]) R package. We retained only protein coding transcripts and used fiveUTRsByTranscript, threeUTRsByTranscript, cdsBy, intronsByTranscript and promoters functions to extract 5ʹ UTRs, 3ʹ UTRs, coding sequences, introns and promoters, respectively. We defined promoters as sequences 2000 bp upstream and 200 bp downstream of the annotated transcription start sites.

#### Polyadenylation sites {#s4-6-1-2}

We downloaded the coordinates of experimentally determined human polyadenylation sites from the PolyASite database (version r1.0) ([@bib30]). After converting the coordinates to the GRCh38 reference genome with CrossMap ([@bib82]), we extended each polyadenylation site to ±25 bp from the center of the site.

#### Chromatin accessibility {#s4-6-1-3}

We downloaded the coordinates of accessible chromatin regions in macrophages across four conditions (N, I, S, I + S) from our previous study ([@bib3]). Specifically, we downloaded the ATAC_peak_metadata.txt.gz file from Zenodo (<https://doi.org/10.5281/zenodo.1170560>).

#### RNA-binding proteins {#s4-6-1-4}

We downloaded processed eCLIP ([@bib75]) peak calls for 93 RNA binding proteins (RBPs) ([@bib76]) from the ENCODE web site (<https://www.encodeproject.org>). Each protein was measured in two biological replicates, resulting in 186 sets of peaks. We only used data from the K562 myelogenous leukemia cell line. We further used Supplementary Table 1 from ([@bib76]) to identify a subset of 29 RBPs that have previously been implicated in splicing regulation, five factors that have been implicated in 3ʹ end processing and two factors (SRSF7 and HNRNPK) that have been implicated in both. Within each group (splicing, 3ʹ end processing and both), we first removed all peaks that were detected only once and then merged all peaks into a single genomic annotation.

### Enrichment analysis {#s4-6-2}

We used fgwas v0.3.6 ([@bib64]) with the '-fine' option to identify the genomic annotations in which different types of QTLs were enriched. We converted QTLtools p-values to z-scores using the stats.norm.ppf(p/2, loc = 0, scale = 1) function from SciPy ([@bib35]), where p is the nominal p-value from QTLtools. The sign of the z-score was determined based on the sign of the QTL effect size. We included all genomic annotations into a joint fgwas model using the '-w' option. For the enrichment analysis, we used QTLs from the naive condition only, but we found that the enrichments patterns were very similar in all stimulated conditions.

Context-specificity of expression and transcript usage QTLs {#s4-7}
-----------------------------------------------------------

To identify response QTLs, we started with QTLs detected (FDR \< 10%) in each of the four stimulated conditions (I, S, I + S and acLDL) and used an interaction test to identify cases where the QTL effect size was significantly different between one of the stimulated and corresponding naive condition (FDR \< 10%). We performed this test separately for each of the four stimulated condition (I, S, I + S and AcLDL). Furthermore, to take advantage of our profiling of gene expression in overlapping set of donors in the stimulated and naive conditions, we also included the cell line as a random effect and fitted a linear mixed model using the lme4 ([@bib8]) package. Specifically, for each phenotype and lead variant pair, we used the anova function to compare the following two models:

H0: phenotype \~genotype + condition + (1\|donor)

H1: phenotype \~genotype + condition+condition:genotype + (1\|donor)

where (1\|donor) denotes the donor-specific random effect. We obtained the p-value of rejecting the null hypothesis and used the p.adjust function to identify phenotype and lead variant pairs that were significant at 10% Benjamini-Hochberg FDR.

For some QTLs, we noticed that although the interaction test p-value was significant, the difference in the effect size between the two conditions was very small. To identify response QTLs with large effect size differences between naive and stimulated conditions, we turned to variance component analysis. Specifically, for the same phenotype and lead variant pairs tested above, we also fitted the following linear mixed model:

phenotype \~ (1\|genotype) + (1\|condition) + (1\|condition:genotype)

where genotype, condition and the interaction between the two were all fitted as random effects. We then quantified the variance explained by each of the three components using the VarCorr function form the lme4 package. Finally, we calculated the variance explained by the interactions term relative to the total genetic variance:

σ^2^~relative~ = σ^2^~interaction~ /(σ^2^~interaction~+σ^2^~genotype~)

We defined response QTLs as those with FDR \< 10% from the interaction test and σ^2^~relative~ \> 0.5 from the variance component analysis. Although fitting genotype as a random effect in this way is suboptimal because it ignores the expected linear relationship between the alternative allele dosage and phenotype, we empirically found that filtering both on the p-value of the interaction test as well as σ^2^~relative~ was effective at identifying QTLs with large effect size differences between conditions.

Overlap with genome-wide association studies {#s4-8}
--------------------------------------------

### Summary statistics {#s4-8-1}

We obtained full summary statistics for ten immune-mediated disorders: inflammatory bowel disease (IBD) including ulcerative colitis (UC) and Crohn's disease (CD) ([@bib50]), Alzheimer's disease (AD) ([@bib43]), rheumatoid arthritis (RA) ([@bib58]), systemic lupus erythematosus (SLE) ([@bib12]), type one diabetes (T1D) ([@bib59]), schizophrenia (SCZ) (Schizophrenia Working Group of the [@bib69]), multiple sclerosis (MS) ([@bib11]), celiac disease (CEL) ([@bib74]) and narcolepsy (NAR) ([@bib24]). We also obtained summary statistics for type two diabetes (T2D) ([@bib53]), cardiovascular disease (CAD) ([@bib55]; [@bib56]) and myocardial infarction (MI) ([@bib56]). Finally, we obtained summary statistics for 20 cardiometabolic traits from a recent meta-analysis ([@bib34]). Summary statistics for T1D, CEL, IBD, RA, AD, MS and SLE were downloaded in 2015. SCZ, T2D and NAR were downloaded in 2016. T2D summary statistics were converted from GRCh36 to GRCh37 coordinates using the LiftOver tool, all the other summary statistics already used GRCh37 coordinates.

### Colocalisation analysis {#s4-8-2}

We used coloc v2.3--1 ([@bib29]) to test for colocalisation between gene expression and transcript usage QTLs and GWAS hits. We ran coloc on a 400 kb region centered on each lead eQTL and tuQTL variant that was less than 100 kb away from at least one GWAS variant with a nominal p-value\<10^−5^. We used the following prior probabilities: p1 = 10^−4^, p2 = 10^−4^ and p12 = 10^−5^. We then applied a set of filtering steps to identify a stringent set of eQTLs and tuQTLs that colocalised with GWAS hits. Similarly to a previous study ([@bib31]), we first removed all cases where PP3+PP4 \<0.8, to exclude loci where we were underpowered to detect colocalisation. We then required PP4/(PP3+PP4) \>0.9 to only keep loci where coloc strongly preferred the model of a single shared causal variant driving both association signals over a model of two distinct causal variants. We excluded all colocalisation results from the MHC region (GRCh38: 6:28,510,120--33,480,577) because they were likely to be false positives due to complicated LD patterns in this region. We only kept results where the minimal GWAS p-value was \<10^−6^. Plots illustrating the sharing of colocalised GWAS signals by different quantification methods were made using UpSetR ([@bib16]).

Code availability {#s4-9}
-----------------

The Snakemake ([@bib41]) files used for gene and transcript expression quantification, QTL mapping and colocalisaton are available from the project's GitHub repository (<https://github.com/kauralasoo/macrophage-tuQTLs>; copy archived at <https://github.com/elifesciences-publications/macrophage-tuQTLs>; [@bib5]). The same repository also contains R scripts that were used for all data analysis and figures. The txrevise R package is available from GitHub (<https://github.com/kauralasoo/txrevise>; copy archived at <https://github.com/elifesciences-publications/txrevise>; [@bib4]) and wiggleplotr R package that was used to make transcript read coverage plots is available from Bioconductor (<http://bioconductor.org/packages/wiggleplotr/>).

Data availability {#s4-10}
-----------------

RNA-seq data from the acLDL stimulation study is available from ENA (PRJEB20734) and EGA (EGAS00001000876). RNA-seq data from the IFNɣ+*Salmonella* study is available from ENA (PRJEB18997) and EGA (EGAS00001002236). The imputed genotype data for HipSci cell lines is available from ENA (PRJEB11749) and EGA (EGAD00010000773). Processed data and QTL summary statistics are available from Zenodo: <https://zenodo.org/communities/macrophage-tuqtls/.>
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Genetic effects on promoter usage are highly context-specific and contribute to complex traits\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Stephen Parker as the Reviewing Editor and Mark McCarthy as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Roger Pique-Regi (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Most transcript usage QTL (tuQTL) studies do not differentiate between events leading to differential isoform usage, such as alternative promoter, alternative 3ʹ end, or alternative splicing that are a likely consequence of different molecular mechanisms. Alasoo and colleagues describe the development of such a tool -- txrevise, which processes (Ensembl) transcript annotations to build an annotation of independent promoters, internal exons and 3\' ends for use with an external tool such as Salmon for transcript quantification. They additionally map genetic associations for total gene expression, full length transcript usage and exon-exon junction using established methods and compare the approaches and results to those from txrevise. The authors show that promoter usage QTLs are generally more context specific and colocalize with genetic signals for complex traits. The approach is sound, and the methods/observations will be helpful to the field. The paper is well-written and we think will be appealing to a broad audience. However, there are several points that should be addressed, which we outline below.

Essential revisions:

1\) There were two QTL scans done, where the initial scan happened over a smaller window. Was there any instance where the larger +/- 500 kb scan resulted in a stronger signal compared to the initial +/- 100 kb scan? If so, how were these treated?

2\) More details about assignment of groups 1 and 2 during the txrevise process would be helpful. Surely there are examples that are not as simple as the one depicted in Figure 1---figure supplement 3. How are those more complicated cases treated? Another way of phrasing this: how do you decide when to choose more exons vs. fewer transcripts? Clarification of this approach will be helpful.

3\) The word \"group\" may have different meanings in different sections of the txrevise methods. For example, in the last paragraph of the subsection "Quantifying transcriptional events with txrevise", \"group\" describes the two different approaches to creating common scaffolds. At the end of the same section of the Materials and methods, it\'s not clear here what \"group\" means. Does it mean as above (the two different scaffold approaches) or one of the three different categories (promoter, internal, 3ʹ UTR)? Clarity here will be helpful for other labs that want to use this approach.

4\) Not clear how multiple testing correction happens with txrevise -- are you using the \--grp-best flag across all the separate bits (promoter, internal, 3ʹ UTR) of a gene model, or only within the three different partitions? And what about across the two groups that are created? When mapping multiple QTLs, it is not clear if the authors map them all simultaneously or if they use a conditional on the lead QTL strategy. The authors should clarify this.

5\) In Figure 2B, authors performed a replication analysis of QTLs. This appears to be only based on the LD between the lead QTL variants for different comparisons. However, the direction of effect size is ignored. This should also be included in all the replication analyses.

6\) Given that promoter shifts are an important component of context specific tuQTL and are also enriched for complex traits, the authors could use their ATAC-seq data to further illustrate the mechanism and perhaps validate. Are changes on promoter usage dependent on the promoters being open? Do these types of tuQTL also have a QTL on ATAC-seq on the promoters? Even if the outcome is negative, which might indicate a more complex relationship between promoter usage and chromatin accessibility, this would further strengthen the manuscript.

7\) The coupling part was uniformly perceived as weaker compared to the rest of the work and could be removed as it is a bit orthogonal to the main focus, especially considering it is not tied to any main figure.

10.7554/eLife.41673.040

Author response

> Essential revisions:
>
> 1\) There were two QTL scans done, where the initial scan happened over a smaller window. Was there any instance where the larger +/- 500 kb scan resulted in a stronger signal compared to the initial +/- 100 kb scan? If so, how were these treated?

We have now modified the section "Association testing" in Materials and methods to clarify that only the lead variants identified in the initial +/- 100 kb scan were used for all downstream analyses. Since genes often have multiple independent eQTLs, we think it is likely that a larger scan in a +/- 500kb window will sometimes identify stronger signals. However, we did not quantify this, because the summary statistics from the larger window were only used for colocalisation analysis based on the lead variants identified in the smaller +/- 100kb. We did this to ensure that all of the variants in the +/- 200kb region around the lead QTL variant were included in the colocalisation analysis, because truncated summary statistics can lead to overestimation of the posterior probability of colocalisation.

> 2\) More details about assignment of groups 1 and 2 during the txrevise process would be helpful. Surely there are examples that are not as simple as the one depicted in Figure 1---figure supplement 3. How are those more complicated cases treated? Another way of phrasing this: how do you decide when to choose more exons vs. fewer transcripts? Clarification of this approach will be helpful.

We agree that, in general, it is not easy to automatically decide whether to prioritise more shared exons between transcripts or larger number of transcripts; indeed, txrevise does not solve this particular problem. We have now modified the legend for Figure 1---figure supplement 3 to clarify that for each gene, txrevise always identifies two groups of transcripts and then performs all of the analyses across the two groups.

> 3\) The word \"group\" may have different meanings in different sections of the txrevise methods. For example, in the last paragraph of the subsection "Quantifying transcriptional events with txrevise", \"group\" describes the two different approaches to creating common scaffolds. At the end of the same section of the Materials and methods, it\'s not clear here what \"group\" means. Does it mean as above (the two different scaffold approaches) or one of the three different categories (promoter, internal, 3\' UTR)? Clarity here will be helpful for other labs that want to use this approach.

We thank the reviewer for pointing out these inconsistencies. We have now edited the text in the Materials and methods section (subsection "Quantifying transcriptional events with txrevise") and in the caption for Figure 1---figure supplement 3. In particular, the term "group" now always refers to the subset of transcripts used to identify the scaffold for event constructions. For the three different categories (promoter, internal exons, 3ʹ ends) we now consistently use the term "types of transcriptional events".

> 4\) Not clear how multiple testing correction happens with txrevise -- are you using the \--grp-best flag across all the separate bits (promoter, internal, 3\' UTR) of a gene model, or only within the three different partitions? And what about across the two groups that are created? When mapping multiple QTLs, it is not clear if the authors map them all simultaneously or if they use a conditional on the lead QTL strategy.

We have now modified the "Association testing" subsection in the Materials and methods to clarify that the permutations were performed across the two subsets of transcripts used for event construction, thus reporting at most three tuQTLs per gene, i.e. one for each event type (promoters, internal exons, 3ʹ ends). After identifying permutation p-values with QTLtools, we also use Benjamini-Hochberg correction to account for the number of independent features that we have tested. Thus, even though we test 3x more features with txrevise, we account for that by using the Benjamini-Hochberg correction. We have also clarified that we mapped multiple QTLs only in the txrevise and Leafcutter analyses, because with those approaches we tested multiple event types (promoters, internal exons, 3ʹ ends) or multiple intron clusters per gene. We did not use conditional analysis.

> 5\) In Figure 2B, authors performed a replication analysis of QTLs. This appears to be only based on the LD between the lead QTL variants for different comparisons. However, the direction of effect size is ignored. This should also be included in all the replication analyses.

The replication analysis is only presented to highlight the fact that different quantification approaches detect complementary sets of genetic associations. Including the effect size direction in our analysis can only reduce the number of QTLs that replicate between methods and not increase it. Therefore, this would not change the conclusions of our analysis.

Nonetheless, we agree that including effect direction in the replication analysis would be beneficial in principle. However, defining the direction of effect in such a way that is consistent between different quantification methods is challenging. For eQTLs, a reasonable definition would be the effect size of the alternative allele on the total read count originating from the gene. However, this becomes much more challenging for full-length transcript usage QTLs, because any variant that is associated with the increased usage of one transcript is by definition also associated with decreased usage of some other transcripts of the gene (since all transcripts have to sum up to 1). Thus, it is not clear which transcript should be used to define the direction of the effect. Similarly, it is challenging to compare the direction of effect sizes between Leafcutter tuQTLs and full-length tuQTLs, because it is not clear how to map Leafcutter splicing events to specific Ensembl transcripts, especially if Leafcutter analysis includes novel splice junctions not present in Ensembl. We now explicitly acknowledge this limitation of our analysis in the Materials and methods section (subsection "QTL replication between quantification methods").

> 6\) Given that promoter shifts are an important component of context specific tuQTL and are also enriched for complex traits, the authors could use their ATAC-seq data to further illustrate the mechanism and perhaps validate. Are changes on promoter usage dependent on the promoters being open? Do these types of tuQTL also have a QTL on ATAC-seq on the promoters? Even if the outcome is negative, which might indicate a more complex relationship between promoter usage and chromatin accessibility, this would further strengthen the manuscript.

We thank the reviewers for this excellent suggestion. We have now performed additional analysis assessing the overlap between promoter usage QTLs that we detect in our current study and chromatin accessibility QTLs that we have reported previously (Alasoo et al., 2018). These analyses revealed that 6% of the promoter usage QTLs are linked to putative coordinated changes in promoter accessibility (r^2^ \> 0.9 between the lead variants) (subsection "Genomic properties of transcript usage QTLs", third paragraph). To illustrate how this can yield mechanistic insight into promoter usage QTLs, we now also discuss one such example in more detail, as shown in Figure 2---figure supplement 7. We further describe this analysis in the Discussion, noting that although the overlap that we detected is small, this is likely influenced by low power in our chromatin accessibility dataset that contained only 41 individuals (Discussion, second paragraph).

> 7\) The coupling part was uniformly perceived as weaker compared to the rest of the work and could be removed as it is a bit orthogonal to the main focus, especially considering it is not tied to any main figure.

We thank the reviewers for the suggestion. We initially added this section to justify the need for event-level analysis. However, we agree that it is orthogonal to the main focus of the paper and we have now removed this section as well as Supplementary Figure 8 from the manuscript. We have also removed the related section from the Discussion.
